Frazier Healthcare Partners announced today the closing of Frazier Life Sciences X, L.P., exceeding its target and closing on more than $617 million in capital commitments in an oversubscribed fundraise. Investing in life sciences has been a core strategy since the firm’s inception 29 years ago, and Frazier Life Sciences X marks the third dedicated Life Sciences fund, bringing the firm’s total committed capital raised since inception to nearly $4.8 billion. Led by General Partners Patrick Heron, James Topper and Dan Estes, the Frazier Life Sciences team invests primarily in therapeutics-focused companies developing and commercializing innovative biopharmaceuticals that address important unmet medical needs.
Read the full article: Frazier Healthcare Partners Closes Oversubscribed $617M Life Sciences Fund //
Source: https://www.prnewswire.com/news-releases/frazier-healthcare-partners-closes-oversubscribed-617-million-life-sciences-fund-300988095.html